Magyar Immunológiai Társaság IMPULSE Szimpózium (Mátraháza, 2013.08.31-09.03.)
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Tudományos információ: Anna ERDEI, Gabriella SÁRMAY, Imre KACSKOVICS, János MATKÓ, Attila MÓCSAI, György PANYI, József PRECHL Címe: www.impulse.org.hu E-mail: impulse@impulse.org.hu Munkahely neve: Arts and Graphs (Conference Secreteriat) E-mail: impulse@impulse.org.hu Helyszín: Mátraháza, A rendezvény Web oldala: http://www.impulse.org.hu IMPULSE: IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013, an EFIS-EJI Symposium
Deadline for submission of abstracts: July 1, 2013
Early registration: June 15, 2013
Further information is available on the website.
EFIS bursaries (covering registration fee and full accomodation) for talented scientist under 35 are still available. Applicants have to send their abstract and CV to matko@elte.hu and cc to anna.erdei@freemail.hu
Make sure to submit your abstract in time and don't forget to apply for an EFIS bursary if you are under 35!
SCIENTIFIC PROGRAM
Molecular mechanisms and therapeutic targets in inflammation
MAJOR TOPICS:
-B cells
-T cells
-Ion channels and inflammation
-Therapeutic targets in inflammation
-Microvesicles & Inflammation or Disease
-Development and application of therapeutic antibodies in inflammatory diseases Kapcsolódó dokumentumok (2)
Magyar Dermatológiai Társulat IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Helyszín: Mátraháza, Residence Ózon**** Conference & Wellness Hotel A rendezvény Web oldala: http://www.impulse.org.hu/venue-and-accommodation.html The subject of the 2013 IMPULSE symposium will be
"Molecular mechanisms and therapeutic targets in inflammation".
The meeting will bring together basic scientists, clinicians and representatives of the pharmaceutical industry to discuss the understanding and therapy of inflammatory diseases.
IMPULSE 2013 will focus on the following topics:
B cells as therapeutic targets
Therapeutic targeting of T cells
Ion channels and inflammation
Therapeutic targets in inflammation
Microvesicles & Inflammation/Disease
Development and application of therapeutic antibodies in inflammatory diseases
Participants with academic, clinical and industrial relations are kindly invited to create this melting pot: IMPULSE
Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság 24th IMDRF session Berlin
Rendezvény kezdete: 2023.09.25.Rendezvény vége: 2023.09.26. Helyszín: Germany, Berlin, Dear Member of Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság, We are contacting your association regarding the upcoming EU-Chaired 24th session of the International Medical Device Regulators Forum (IMDRF) taking place in Berlin, Germany. We invite you to register and join the open session meetings on 25-26 September 2023. We would also encourage you to share this message with your association’s members, specifically medical device manufacturers. Register now Where? InterContinental Berlin to benefit from discounted hotel room rates by 21 August, click here . What?Joint IMDRF - Stakeholder Workshop (Day 1 - 25 September) Stakeholder Open Forum (Day 2 - 26 September) The EU-Chaired 24th session of the IMDRF will gather international professionals in the medical device regulatory field and provide a valuable opportunity for exchange between participating authorities, industry and clinical associations. Day 1: A workshop on ‘Specialised Regulatory Pathways’ will take place on 25 September. In addition, a dedicated information session on the recent Medical Devices Regulation (EU) 2017/745 (MDR) amendment will be held. Day 2: The IMDRF Stakeholder Forum will take place on 26 September. This will be your opportunity to hear the latest updates from international regulators and stakeholder representatives and participate in an exchange with panellists on a range of interesting topics. The physical meetings planned for these two days in Berlin will significantly contribute to the IMDRF's work over the coming year. Join the discussion